A Study of SR-8541A in Combination With Botensilimab and Balstilimab in People With Colorectal Cancer

Full Title

Phase 2 Study of SR-8541A in Combination with Botensilimab and Balstilimab in Subjects with Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC) (SR-8541A-002)

Purpose

To learn more about the purpose of this study and to find out who can join, please click here to visit ClinicalTrials.gov for a full clinical trial description.

Contact

For more information or to see if you can join this study, please call Dr. Neil Segal’s office at 646-888-4187.

Protocol
26-270
Phase
Phase II (phase 2)
Disease Status
Relapsed or Refractory
Investigator
Neil H. Segal
Co-Investigators
Maliha Nusrat
Diseases
Colorectal Cancer
Locations
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Commack Nonna’s Garden Foundation Center
Memorial Sloan Kettering Basking Ridge
Memorial Sloan Kettering Westchester
Memorial Sloan Kettering Monmouth
Memorial Sloan Kettering Bergen
Memorial Sloan Kettering Nassau
ClinicalTrials.gov ID
NCT06589440
ClinicalTrials.gov
Visit ClinicalTrials.gov for full clinical trial description